EVEXIA LIFECARE LIMITED

BSE: EVEXIA524444ISIN INE313M01030

Commodities
Trading - Chemicals

BSE listing

Share price

₹1.78+0.05 (+2.89%)

as of 18 Sep 2026

52W high: ₹2.23
52W low: ₹0.47
Off 52W high: -20.18%
1M return: +31.85%
3M return: +7.23%
6M return: +154.29%
1Y return: -18.72%
20D avg volume: 3,08,42,142
50 DMA: ₹1.50
200 DMA: ₹1.44

Key ratios Consolidated

Market cap: ₹334.16 Cr
Current price: ₹1.78
52W high / low: ₹2.23 / ₹0.47
Face value: ₹1.00
P/E: 179.38
P/B: —
EPS (TTM): ₹0.01
Book value / share: —
ROE: —
ROCE: 0.30%
Operating margin: —
Net margin: —
Debt / equity: 0.01
Net debt: ₹0.51 Cr
Interest cover: 221.00
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 102.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	30.89	36.79	25.24	25.73	22.09	23.61	—
	0.15	0.10	0.26	0.43	0.00	0.00	—
	30.48	35.99	25.11	25.65	21.24	23.17	—
	0.04	0.00	0.00	0.00	0.00	2.08	—
	29.67	35.10	24.09	24.70	20.67	18.06	—
	0.06	0.35	0.23	0.13	0.38	2.21	—
	0.01	0.00	0.00	0.00	0.01	0.41	—
	0.11	0.30	0.12	0.03	0.21	0.46	—
	0.19	0.58	0.55	0.41	0.36	3.39	—
	0.57	0.90	0.39	0.51	0.86	0.44	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.57	0.90	0.39	0.51	0.86	0.44	—
	0.15	0.12	0.10	0.14	0.22	0.14	—
	0.42	0.78	0.29	0.37	0.63	0.31	—
	0.00	0.00	0.00	0.00	0.03	0.00	—
Key metrics
	0.69	1.20	0.51	0.54	1.08	1.31	—
	2.20%	3.30%	2.00%	2.10%	4.90%	5.50%	—
	1.40%	2.10%	1.10%	1.40%	2.90%	1.30%	—
	—	0.10%	—	0.00%	—	0.10%	—
	39.80%	55.80%	—	—	—	—	—
	-33.30%	151.60%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	118.65	110.28	110.48	—
	0.94	0.00	0.14	—
	117.23	108.08	109.19	—
	0.04	0.00	0.07	—
	113.56	104.76	90.70	—
	0.77	1.54	5.78	—
	0.01	0.01	1.09	—
	0.56	0.66	1.70	—
	1.73	1.34	11.79	—
	2.37	2.20	1.44	—
	0.00	0.00	0.00	—
	2.37	2.20	1.44	—
	0.51	0.58	0.51	—
	1.86	1.62	0.93	—
	0.00	0.00	0.01	—
Key metrics
	2.94	2.87	4.23	—
	2.48%	2.60%	3.80%	—
	1.57%	1.50%	0.80%	—
	—	0.30%	0.30%	—
	—	-0.20%	—	—
	—	74.20%	—	—
	—	-26.71	-6.75	—
	—	-14.49	0.31	—
	—	0.01	0.83	—
	—	0.51	381.63	—
	—	102.5	106.0	—
Balance sheet
	—	872.42	920.37	—
	—	94.20	118.40	—
	—	2.38	4.14	—
	—	84.89	92.91	—
	—	2.57	2.75	—
	—	1.60	7.64	—
	—	17.99	22.38	—
	—	56.49	63.59	—
	—	62.74	79.31	—
	—	2.89	385.77	—
	—	2.45	11.26	—
	—	0.44	374.51	—
	—	434.44	466.39	—
Cash flow
	—	-23.48	0.29	—
	—	52.68	-28.93	—
	—	-27.65	32.03	—
	—	3.23	7.04	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	29.66	35.18	24.60	25.03	20.66	15.18	—
	0.02	0.55	0.26	0.34	0.00	0.03	—
	29.12	35.16	24.31	24.94	19.86	15.56	—
	0.00	0.00	0.00	0.00	0.00	-2.58	—
	28.84	34.12	23.48	24.01	19.81	17.32	—
	0.06	0.16	0.17	0.17	0.17	0.20	—
	0.00	0.00	0.00	0.00	0.01	0.31	—
	0.11	0.31	0.12	0.12	0.12	0.16	—
	0.18	0.25	0.42	0.20	0.23	0.57	—
	0.56	0.57	0.55	0.43	0.79	-0.35	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.56	0.57	0.55	0.43	0.79	-0.35	—
	0.15	0.10	0.14	0.11	0.21	0.14	—
	0.41	0.47	0.41	0.32	0.59	-0.49	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
Key metrics
	0.67	0.88	0.67	0.55	0.92	0.12	—
	2.30%	2.50%	2.70%	2.20%	4.50%	0.80%	—
	1.40%	1.30%	1.70%	1.30%	2.90%	-3.20%	—
	—	0.10%	—	0.10%	—	0.00%	—
	43.60%	131.80%	—	—	—	—	—
	-30.50%	195.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	114.47	105.46	83.89	—
	1.17	0.89	0.14	—
	113.53	104.29	82.82	—
	0.00	0.00	0.07	—
	110.45	101.42	81.54	—
	0.56	0.67	0.74	—
	0.00	0.01	0.36	—
	0.66	0.66	0.47	—
	1.05	1.13	1.27	—
	2.11	2.06	1.20	—
	0.00	0.00	0.00	—
	2.11	2.06	1.20	—
	0.50	0.53	0.48	—
	1.61	1.52	0.73	—
	0.00	0.00	0.01	—
Key metrics
	2.77	2.73	2.03	—
	2.42%	2.60%	2.40%	—
	1.41%	1.40%	0.90%	—
	—	0.30%	0.20%	—
	—	25.70%	—	—
	—	108.20%	—	—
	—	-22.88	-6.20	—
	—	-15.05	-8.12	—
	—	0.00	0.86	—
	—	-0.09	374.14	—
	—	115.1	152.5	—
Balance sheet
	—	864.30	864.27	—
	—	85.36	94.40	—
	—	0.09	0.03	—
	—	82.74	87.46	—
	—	1.67	2.08	—
	—	0.86	4.45	—
	—	9.85	10.52	—
	—	51.17	54.47	—
	—	52.36	55.26	—
	—	0.00	374.17	—
	—	0.00	0.00	—
	—	0.00	374.17	—
	—	437.14	434.69	—
Cash flow
	—	-22.88	-5.93	—
	—	21.92	-14.51	—
	—	1.02	20.08	—
	—	0.00	-0.27	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 3.37%

Holder	Type	Holding	Previous	Change
Wave Capital Ltd	Public	12.17%	—	—
Nova Global Opportunities Fund Pcc - Touchstone	Public	8.07%	—	—
Moolchand Kiran Kumar Jain	Public	5.86%	—	—
Aio Growth Capital Fund Spc	Public	4.72%	—	—
M7 Global Fund Pcc - Cell Dewcap Fund	Public	3.94%	—	—
Zeal Global Opportunities Fund	Public	2.34%	—	—
R G Family	Public	2.31%	—	—
Global Focus Fund	Public	2.29%	—	—
Nishchaya Tradings Private Limited	Public	1.98%	—	—
Raghuvir International	Promoter Group	1.55%	—	—
Jayeshbhai Raichand Bhai Thakkar	Promoter	1.30%	—	—
Ravi Goyal	Public	1.23%	—	—
Abhay Bharatbhai Shah	Public	1.16%	—	—
Artiben Jayeshbhai Thakkar	Promoter	0.24%	—	—
Thakkar Jaswantbhai Raychandbhai	Promoter	0.07%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd19 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Disclosure18 Sep 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd18 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd18 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Disclosure17 Sep 2026 · Company Update / General
Intimation of Disclosure17 Sep 2026 · Company Update / General
Intimation of Newspaper Publication12 Sep 2026 · Company Update / Newspaper Publication
Outcome of Board Meeting held on September 11, 202611 Sep 2026 · Others / Outcome without intimation
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd11 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Disclosures10 Sep 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd9 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of book closure8 Sep 2026 · Corp. Action / Book Closure
Outcome of Board Meeting held on September 08, 20268 Sep 2026 · Others / Outcome without intimation
Intimation of Disclosures8 Sep 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd4 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Disclosure4 Sep 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd4 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Disclosures3 Sep 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd3 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Saibaba Exim Pvt Ltd3 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Disclosures2 Sep 2026 · Company Update / General
Intimation of Newspaper Publication8 Aug 2026 · Company Update / Newspaper Publication
Intimation of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 20267 Aug 2026 · Result / Financial Results
Outcome of Board Meeting held on August 07, 20267 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation for Board Meeting to be held on Friday, August 07, 2026 for the approval of Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 20265 Aug 2026 · Company Update / General
Evexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....4 Aug 2026 · Board Meeting / Board Meeting
Certificate under Reg 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended 30-06-202611 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading Window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of ASCR-31-03-202624 Jun 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kiran Kumar Jain M19 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Zeal Global Opportunities Fund FCCB11 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kiran Kumar Jain M11 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kiran Kumar Jain M8 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of Scrutinizer Report19 May 2026 · AGM/EGM / AGM
Intimation of proceedings of 34th AGM of the Company15 May 2026 · AGM/EGM / AGM
Intimation of Newspaper Publication15 May 2026 · Company Update / Newspaper Publication
Audited Financial Result for the quarter and year ended 31-03-20269 May 2026 · Result / Financial Results
BM Outcome9 May 2026 · Board Meeting / Outcome of Board Meeting
Evexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 ,inter alia, to consider and approve Audited Financial Results (Standalone ....6 May 2026 · Board Meeting / Board Meeting
Intimation of publication of public notice of 34th AGM24 Apr 2026 · Company Update / Newspaper Publication

Board meetings

7 Aug 2026 Board Meeting - Financial Results